-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Wo5Ok7i60AVNZ/vX/wed2ZrUWx4P/lKoh6PZDtDQN8LHodq4nvIrcT34E0jdV3SR fPKN9fT6fnWB8qtvxV7Ykg== 0001014156-05-000001.txt : 20050104 0001014156-05-000001.hdr.sgml : 20050104 20050104160633 ACCESSION NUMBER: 0001014156-05-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20041231 FILED AS OF DATE: 20050104 DATE AS OF CHANGE: 20050104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WATTLETON FAYE CENTRAL INDEX KEY: 0001014156 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 05507463 BUSINESS ADDRESS: STREET 1: 25 WEST 43RD STREET STREET 2: SUITE 1014 CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212 391 7718 MAIL ADDRESS: STREET 1: 767 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10153 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2004-12-31 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001014156 WATTLETON FAYE 300 CENTRAL PARK WEST APT. 15H NEW YORK NY 10024 1 0 0 0 Common stock, $.01 par value per share 2004-12-31 4 A 0 1383 2.71 A 4920 D Options to purchase common stock, $.01 par value per share 2.71 2004-12-31 4 A 0 5000 2.71 A 2005-12-31 2014-12-31 Common Stock, $.01 par value per share 5000 100625 D These shares were granted pursuant to the Company's 2004 Incentive Plan, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $3,750.00, until she is no longer an Outside Director. On December 31, 2004, the fair market value of the Common Stock, based on the closing price, was $2.71 These options will become fully vested and immediately exercisable on 12/31/2005. Beata Smith as Attorney-in-Fact for Faye Wattleton 2005-01-04 EX-24 2 wattleton.htm
POWER OF ATTORNEY



Know all by these presents, that the undersigned hereby constitutes and

appoints each of Philip K. Yachmetz, Esq. and Beata A. Smith, signing singly, the

undersigned's true and lawful attorney-in-fact to:



(1) execute for and on behalf of the undersigned, in the undersigned's capacity

as an officer and/or director of Savient Pharmaceuticals, Inc.(the "Company"),

Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange

Act of 1934 and the rules thereunder;



(2) do and perform any and all acts for and on behalf of the undersigned which

may be necessary or desirable to complete and execute any such Form 3, 4, or 5,

complete and execute any amendment or amendments thereto, and file such form

with the United States Securities and Exchange Commission and any stock

exchange or similar authority; and



(3) take any other action of any type whatsoever in connection with the

foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,

in the best interest of, or legally required by, the undersigned, it being

understood that the documents executed by such attorney-in-fact on behalf of

the undersigned pursuant to this Power of Attorney shall be in such form and

shall contain such terms and conditions as such attorney-in-fact may approve in

such attorney-in-fact's discretion.



The undersigned hereby grants to each such attorney-in-fact full power and

authority to do and perform any and every act and thing whatsoever requisite,

necessary, or proper to be done in the exercise of any of the rights and powers

herein granted, as fully to all intents and purposes as the undersigned might

or could do if personally present, with full power of substitution or

revocation, hereby ratifying and confirming all that such attorney-in-fact, or

such attorney-in-fact's substitute or substitutes, shall lawfully do or cause

to be done by virtue of this power of attorney and the rights and powers herein

granted.  The undersigned acknowledges that the foregoing attorneys-in-fact,

in serving in such capacity at the request of the undersigned, are not

assuming, nor is the Company assuming, any of the undersigned's

responsibilities to comply with Section 16 of the Securities Exchange Act of

1934.



This Power of Attorney shall remain in full force and effect until the

undersigned is no longer required to file Forms 3, 4, and 5 with respect to

the undersigned's holdings of and transactions in securities issued by the

Company, unless earlier revoked by the undersigned in a signed writing

delivered to the foregoing attorneys-in-fact.



IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be

executed as of this 30th day of September, 2004.





Signature:  /s/



Print Name: Faye Wattleton
-----END PRIVACY-ENHANCED MESSAGE-----